Clinical Trials Directory

Trials / Completed

CompletedNCT01661309

Supplementary Vitamin B12 Effects on Elevated Homocysteine Levels of Vegetarians - Clinical Trial

To Critically Investigate and Evaluate Supplementary Vitamin B12 Effects on Elevated Homocysteine Levels of Vegetarians, Who May Have a Resultant Susceptibility to Hyperhomocysteinemia Related Diseases.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University of West London · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Vegetarians are known to be deficient in vitamin B12, due to a lack or absence of dietary animal produce, which can elevate homocysteine. There is strong evidence indicating that elevated plasma total homocysteine (tHcy) is a contributor to chronic conditions, such as primary cardiovascular disease (CVD). The study hypothesis is: There will be a significant decrease in plasma tHcy of vegetarians following the intervention by supplementary vitamin B12 (of the methylcobalamin type) and this will lead to a reduction of the risk of CVD.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTInactive lozengeManufactured to mimic 1mg methylcobalamin lozenge
DIETARY_SUPPLEMENTMethylcobalaminAimed at reducing plasma tHcy.

Timeline

Start date
2012-03-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2012-08-09
Last updated
2014-05-20

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01661309. Inclusion in this directory is not an endorsement.